1. Which imperative is likely to be most important to MNCs in this decade: economic, political, or quality?
2. When MNCs scan the environment, what are two key areas of consideration that MNCs must address?
3. Choose one of the pharma companies mentioned in the chapter’s opening World of International Management. How would you characterize its strategy within the globalization-national responsiveness framework?
4. Which FSAs and CSAs does it primarily rely upon? To what extent does the company use a “base-of-pyramid” approach? How would it affect the company if low-income markets turned out to be a bust?